Pioglitazone Inhibits the Development of Hyperalgesia and Sensitization of Spinal Nociresponsive Neurons in Type 2 Diabetes

Journal of Pain - United States
doi 10.1016/j.jpain.2015.11.006
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Preparation and Characterization of Pioglitazone Loaded PLGA Nanospheres for the Treatment of Type 2 Diabetes

Polymer (Korea)
PolymersMaterials ChemistryPlasticsChemical Engineering
2010English

Role of Spinal P38α and Β MAPK in Inflammatory Hyperalgesia and Spinal COX-2 Expression

NeuroReport
Neuroscience
2010English

Epigenetic Mechanisms in the Development of Type 2 Diabetes

Trends in Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2010English

Glycaemic and Nonglycaemic Effects of Pioglitazone in Triple Oral Therapy of Patients With Type 2 Diabetes

Journal of Internal Medicine
Internal Medicine
2006English

The Antinociceptive Effect of Systemic Gabapentin Is Related to the Type of Sensitization-Induced Hyperalgesia

Journal of Neuroinflammation
Molecular NeuroscienceNeurologyImmunologyCellularNeuroscience
2007English

The Use of Pioglitazone and the Risk of Bladder Cancer in People With Type 2 Diabetes: Nested Case-Control Study

British Medical Journal
Medicine
2012English

Comparison of Pioglitazone vs Glimepiride on Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes

JAMA - Journal of the American Medical Association
Medicine
2008English

A Comparison of Lipid and Glycemic Effects of Pioglitazone and Rosiglitazone in Patients With Type 2 Diabetes and Dyslipidemia

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2005English

Fat Intake and the Development of Type 2 Diabetes [Review]

Endocrine Journal
EndocrinologyMetabolismDiabetes
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy